←Back to Expert Scholars
Translational Medicine / 转化医学Advanced Basal Cell Carcinoma
Aleksandar Sekulic
MD, PhD
🏢Mayo Clinic Arizona🌐USA
Professor of Dermatology
55
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Aleksandar Sekulic led the ERIVANCE trial that established vismodegib for advanced basal cell carcinoma. He continues to investigate resistance and optimal use of Hedgehog pathway inhibitors. He is a leader in clinical management of advanced BCC.
Share:
🧪Research Fields 研究领域
basal cell carcinoma
vismodegib
Hedgehog inhibitors
clinical trials
dermato oncology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Aleksandar Sekulic 的研究动态
Follow Aleksandar Sekulic's research updates
留下邮箱，当我们发布与 Aleksandar Sekulic（Mayo Clinic Arizona）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment